“Phase 3 Trial Demonstrates Superior Patient Treatment Convenience of MC2-01 Calcipotriene Plus Betamethasone Dipropionate Cream Compared to Current Topical Suspension”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s62. Accessed May 7, 2026. https://skin.dermsquared.com/skin/article/view/1011.